Dengvaxia refund hindi sapat, gastusin ng mga naapektuhan sagutin – Hontiveros

MANILA, Philippines – Hinamon ni Sen. Risa Hontiveros ngayong Martes ang pharmaceutical firm Sanofi Pasteur na sagutin ang gastusin ng mga naapektuhan ng anti-dengue vaccine Dengvaxia bukod pa sa plano nilang refund.

"Reimbursement is not enough. Over and above its plan to pay back the government for unused Dengvaxia vials, I call on Sanofi to shoulder the health needs of the affected children and compensate their families,” sabi ni Hontiveros.

“The cost after all, is more than just money. There was clear negligence, and the responsible thing to do is for Sanofi to see to the health needs of the affected and compensate their families for the harm they have caused. Regaining the trust of the public is a far more important investment," dagdag niya.

Inamin ng Sanofi na maaaring magkaroong ng severe dengue ang mga nabakunahan ng Dengvaxia na hindi pa nagkakaroon ng dengue.

Abril 2016 sinimulang ipatupad ang programa kung saan nasa 700,000 Grade 4 students mula sa iba’t ibang bahagi ng bansa ang nabakunahan.

BASAHIN: Sanofi pumayag mag-refund sa Dengvaxia

Pumayag ang Sanofi na ibalik ang nasa P1.4 bilyon bilang refund sa mga hindi pa nagagamit na Dengvaxia.

Samantala, nais naman ni Senate President Koko Pimentel na ibalik ng buo ng Sanofi ang nagastos ng gobyerno para sa anti-dengue vaccine.

“All the vaccines were defective from the very beginning. Therefore, under our laws, we should demand the whole ?3.5 billion we paid them and not just part of it,” sabi ni Pimentel.

“The Civil Code says you can have a defective product replaced or refunded. Since there is no possible replacement for the vaccine, refund is the only option.”